Filing Flows › 8-K events › Bridger Aerospace Group Holdings
Bridger Aerospace Group Holdings: notice of delisting or failure to meet a listing standard
Form 8-K filed Oct 30, 2026 · items 3.01
What the filing says
On October 28, 2026, Bridger Aerospace Group Holdings, Inc. (the “Company”) received a deficiency letter (the “Letter”) from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, $0
Read the filing on SEC EDGAR →
What usually followsAcross 492 8-Ks reporting Item 3.01 (delisting notice or listing-rule failure) in our universe, the stock's median move the next session was 0.0% (typical size ±2.1%, up 46% of the time); over the following 21 sessions, −0.2%. Every item ranked →
What this kind of filing means
Item 3.01 — Notice of delisting or failure to meet a listing standard. A delisting notice starts a compliance window; companies often answer with a reverse split, a plan, or a move to another market.
Bridger Aerospace Group Holdings at a glance
Bridger Aerospace Group Holdings, Q2 2026: revenue $30.5M (-0.8% year over year), operating margin -1.6%. The chart follows the revenue to costs, profit and cash.
Bridger Aerospace Group Holdings: every quarter, Q/Q and Y/Y, holders and guidance →
Bridger Aerospace Group Holdings’s other material 8-Ks
Other recent delisting notices
- Barfresh Food Group Nov 6, 2026
- Fifth Era Acquisition Corp I Nov 6, 2026
- Tempest Therapeutics Nov 6, 2026
- Roku Nov 6, 2026
- Bowman Consulting Group Nov 6, 2026
- Knightscope Nov 6, 2026
- Curis Nov 6, 2026
- Intrusion Nov 5, 2026
- Karyopharm Therapeutics Nov 5, 2026
- Cognition Therapeutics Nov 5, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.